8-K 1 a13024.htm FORM 8-K 8-K



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


                                        


FORM 8-K

                                        


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): December 27, 2016


GENERAL CANNABIS CORP

 (Exact Name of Registrant as Specified in Charter)


Colorado

000-54457

20-8096131

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)


6565 E. Evans Avenue
Denver, Colorado

 

80224

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number, including area code: (303) 759-1300


                                                       N/A                                                       

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:


[_]

Written communications pursuant to Rule 425 under the Securities Act

[_]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[_]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

[_]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act





Item 8.01

Other Events.


On December 27, 2016, General Cannabis Corp (the “Company”) issued a press release announcing the effectiveness of its resale registration statement on Form S-1 relating to the sale of up to 9,000,000 shares of the Company’s common stock that may be issued to certain warrant holders upon the exercise of such warrants.


The full text of the press release is attached hereto as exhibit 99.1.


Item 9.01

Financial Statements and Exhibits.


(d)   Exhibits.


Exhibit No.

 

Description

99.1

 

Press release dated December 27, 2016 regarding effectiveness of resale Form S-1.






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Dated: December 30, 2016



 

General Cannabis Corporation

 

 

 

 

 

 

 

By:

/s/ Robert L. Frichtel

 

Name:

Robert L. Frichtel

 

Title:

Chief Executive Officer






EXHIBIT INDEX


Exhibit No.

 

Description

99.1

 

Press release dated December 27, 2016 regarding effectiveness of resale Form S-1.